期刊文献+

丙型肝炎病毒抗体及核酸测定的诊断效能分析 被引量:2

Diagnostic performance of HCV antibody and RNA Determination
下载PDF
导出
摘要 目的探讨丙型肝炎病毒(HCV)感染患者HCV抗体(HCV-Ab)、HCV核糖核酸(HCV-RNA)水平的变化及其在诊断治疗中的意义。方法随机收集临床诊断为HCV感染患者血清,采用化学发光微粒子免疫检测法测定HCV-Ab,PCR-荧光探针法检测HCV-RNA,同时检测丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)。根据ALT、AST水平以及HCV-RNA水平分别分为两组,分析比较两组间各指标的变化。同时收集37例临床抗病毒治疗患者的血清,分析治疗前后各指标的变化。结果肝功异常组HCV-Ab、RNA载量对数值水平均高于肝功正常组(P<0.05)。HCV-RNA阳性组HCV-Ab、ALT、AST水平均高于HCV-RNA阴性组(P<0.05)。HCV-Ab、RNA载量对数值诊断丙型肝炎的ROC曲线下面积分别为0.990、0.838。连续观察病例治疗后ALT、AST、RNA载量对数值水平均较治疗前下降(P<0.05);而HCV-Ab治疗前后差异无统计学意义(P>0.05)。结论 HCV-Ab对于丙型肝炎的诊断效能优于RNA载量对数值。ALT、AST及HCV-RNA检测在丙型肝炎治疗监测过程中有重要临床意义。 Objective To explore changes of anti-HCV antibody and HCV-RNA in patients with HCV infection and its clinical significance in diagnosis and treatment of hepatitis C .Methods Serum samples from patients with HCV infection were collected . HCV antibodies were analyzed with a chemiluminescence micro-particle immunoassay method ,while a PCR-fluorescent probe meth-od was used to detect HCV-RNA .Concentrations of ALT and AST were also determined .Based on the concentrations of ALT , AST and HCV-RNA ,samples were divided into two groups respectively and the changes of different indicators were analyzed and compared .Meanwhile samples from 37 HCV-infected patients were collected continuously .Different indicators after treatment were compared with those before treatment .Results HCV-Ab and logarithm values of RNA load in the group with abnormal concentra-tions of ALT and AST were significantly higher than those in the normal group (P〈0 .05) .HCV-Ab ,ALT and AST concentrations in HCV-RNA positive group were significantly higher than those in HCV-RNA negtive group(P〈0 .05) .The areas under receiver operating characteristic curve of HCV-Ab and logarithm values of RNA load were 0 .990 and 0 .838 respectively .Concentrations of ALT ,AST and logarithm values of RNA load after treatment were significantly lower than those before treatment (P〈0 .05) while there was no significance between HCV-Ab level after treatment and that before treatment (P〉0 .05) .Conclusion The diagnostic performance of HCV-Ab is better than that of logarithm values of RNA load .Determination of ALT ,AST and HCV-RNA is of clinical importance in monitoring the effect of hepatitis C treatment .
出处 《国际检验医学杂志》 CAS 2014年第18期2448-2450,共3页 International Journal of Laboratory Medicine
关键词 丙型肝炎病毒抗体 核糖核酸 诊断效能 hepatitis C virus antibody ribonucleic acid diagnostic performance
  • 相关文献

参考文献16

  • 1Lemon SM, Walker C, Alter MJ, et al. Hepatitis c virus:in fields virology[M]. PA, USA: Lippincott Williams ga Wilkins, 2007: 1253-1304.
  • 2Helle F, Duverlie G, Dubuisson J. The hepatitis C virus glycan shield and evasion of the humoral immune response[J]. Viruses, 2011,3 (10) .. 1909-1932.
  • 3European Association for the Study of the Liver. EASL clinical praetice guidelines:management of hepatitis C virus infection[J]. J Hepato|,2011,55(2) :245-264.
  • 4Maudar KK, Gandhi P, Mishra PK, et al. Novel approach for quantification of hepatitis C virus in liver cirrhosis using real-time reverse transeriptase PCR[J]. J Gastrointest Surg, 2012,16 (1) :142-146.
  • 5Carreo V, Pardo M, L6pez-Alcorocho JM, et al. Detection of hepa titis C virus (HCV) RNA in the liver of healthy, anti-HCV anti body-positive, serum HCV RNA-negative patients with normal al- anine aminotransferase levels[J]. J Infect Dis, 2006,194 ( 1 ) : 53- 60.
  • 6Kesli R, Ozdemir M, Kurtoglu MG, et al. Evaluation and compari- son of three different anti-hepatitis C virus antibody tests based on chemiluminescence and enzyme-linked immunosorbent assay methods used in the diagnosis of hepatitis C infections in Turkey [J]. J Int Med Res,2009,37(5):1420 1429.
  • 7Maylin S, Martinot-Peignoux M, Ripault MP, et al. Sustained viro- _ogica_ response is associated with cearanee of hepatitis C virus RNA and a decrease in hepatitis C virus antibodyFJ]. Liver Int, 2009,29(4) :511-517.
  • 8Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus:quasispeeies and genotypes[J]. Semin Liver Dis, 1995,15 (1) :41-63.
  • 9Rehermann B. Hepatitis C virus versus innate and adaptive im mune responses., a tale of coevolution and coexistence[J]. J Clin Invest,2009,119(7):1745-1754.
  • 10Zhong J, Gastaminza P, Chung J, et al. Persistent hepatitis C virus infection in vitro:coevolution o{ virus and host[J]. J Virol, 2006, 80(22) : 11082-11093.

二级参考文献8

  • 1Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis,2004,4 (12) :725 -738.
  • 2Cariani E, Pollara CP, Valloncini B,et al. Relationship between pp65 antigenemia levels and real - time quantitative DNA PCR for Human Cytomegalovirus management in immunocompromised patients [ J ]. BMC Infect Dis,2007,23(7) :138 -140.
  • 3Lazzarotto T, Guerra B,Lanari M, et al. New advances in the diagnosis of congenital cytomegalovirus infection [ J ]. J Chn Virol, 2008,41 (3) : 192 - 197.
  • 4Reeves M, Sinclair J. Aspects of human cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol,2008,325:297 -313.
  • 5Hedman K, Rousseau SA. Measurement of avidity of specific IgG for verification of recent primary rubella [ J ]. J Med Virol, 1989,27 ( 4 ) : 288 -292.
  • 6Blackburn NK, Besselaar TG,Sehoub BD,et al. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity [ J ]. J Med Virol, 1991,33 (1):6-9.
  • 7Revello MG, Gorini G,Gerna G. Clinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin G avidity to human Cytomegalovirus [ J ]. Clin Diagn Lab Immunol, 2004,11 ( 4 ) : 801 - 805.
  • 8张萌,侯林浦,牛向兰,谷学英,何欢,马旭,霍正浩.巨细胞病毒IgG特异性抗体亲和指数测定方法的研究[J].中国计划生育学杂志,2009,17(6):357-359. 被引量:6

共引文献5

同被引文献8

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部